Retrospective analysis of safety and effectiveness of recombinant thrombomodulin for vascular endothelial syndrome after hematopoietic cell transplantation in children.

Retrospective analysis of safety and effectiveness of recombinant thrombomodulin for vascular endothelial syndrome after hematopoietic cell transplantation in children. - Retrospective analysis of safety and effectiveness of recombinant thrombomodulin for vascular endothelial syndrome after hematopoietic cell transplantation in children.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000022640

Enrollment

Registered

2016-06-09

Start date

2016-05-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric patients who developed vascular endothelial syndrome after hematopoietc cell transplantation.

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who developed vascular endothelial syndrome after hematopoietic cell transplantation.

Exclusion criteria

Exclusion criteria: Patients who did not meet the inclusion criteria. Patients who disagreed to write the consent.

Design outcomes

Primary

Measure	Time frame
Comparison of the duration until improvement of vascular endothelial syndrome between the patients with rTM and without rTM.	—

Countries

Japan

Contacts

Public ContactReo Tanoshima

Yokohama City University Department of Pediatrics

tanoshima-ykh@umin.ac.jp81-45-787-2800

Outcome results